Does Coumadin (warfarin) come in a 2.25 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Coumadin Tablet Strengths

No, Coumadin does not come in a 2.25 mg tablet formulation.

Available Tablet Strengths

According to the FDA-approved drug label, Coumadin (warfarin sodium) tablets are manufactured in the following specific strengths 1:

  • 1 mg (pink tablet with D&C red no. 6 barium lake)
  • 2 mg (lavender tablet)
  • 2.5 mg (green tablet)
  • 3 mg (tan tablet)
  • 4 mg (blue tablet)
  • 5 mg (peach tablet)
  • 6 mg (teal tablet)
  • 7.5 mg (yellow tablet)
  • 10 mg (white, dye-free tablet)

Clinical Implications

If a dose of 2.25 mg is required, you must split tablets to achieve this dose. The most practical approach is to use:

  • One 2 mg tablet plus one-quarter of a 1 mg tablet (2 + 0.25 = 2.25 mg), or
  • Three-quarters of a 3 mg tablet (0.75 × 3 = 2.25 mg), or
  • Alternate between 2 mg and 2.5 mg on different days to achieve an average weekly dose equivalent

Important Dosing Considerations

Warfarin dosing should be individualized based on INR monitoring, not predetermined tablet strengths. The American College of Cardiology recommends:

  • Starting doses of 5 mg daily for most patients, or 2-4 mg daily in elderly patients 2, 3
  • Dose adjustments based on INR values, typically altering the total weekly dose by 5-20% 4
  • Target INR of 2.0-3.0 for most indications 2, 3

Elderly patients often require lower maintenance doses due to increased sensitivity to warfarin's anticoagulant effect 2, 5, which may necessitate unconventional doses like 2.25 mg achieved through tablet splitting.

Practical Pitfall

When splitting tablets or using combinations to achieve specific doses, ensure patients understand the regimen clearly to avoid dosing errors, as warfarin has a narrow therapeutic index where small changes can lead to significant INR fluctuations 4, 6.

References

Guideline

Warfarin Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Warfarin Initiation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management and dosing of warfarin therapy.

The American journal of medicine, 2000

Guideline

Impact of Low Albumin on Free Circulating Warfarin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Warfarin therapy: evolving strategies in anticoagulation.

American family physician, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.